Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Hundreds of COVID trials could provide a deluge of new drugs

A lab technician wearing a face mask and a protective suit works on a production line packaging Molnupiravir

A lab technician works on the production of molnupiravir, an oral antiviral drug that some countries have authorized for use against COVID-19. Credit: Amr Abdallah Dalsh/Reuters/Alamy

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 603, 25-27 (2022)



  1. RECOVERY Collaborative Group N. Engl. J. Med. 384, 693–704 (2021).

    Article  PubMed  Google Scholar 

  2. Zhou, S. et al. J. Infect Dis. 224, 415–419 (2021).

    Article  PubMed  Google Scholar 

  3. White, K. M. et al. Science 371, 926–931 (2021).

    Article  PubMed  Google Scholar 

  4. Arribas, J. R. et al. N. Engl. J. Med. Evid. (2021).

    Article  Google Scholar 

Download references


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links